An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors.

Mora, M

An in vivo model of hyperacute rejection: characterization and evaluation of the effect of transgenic human complement inhibitors. [electronic resource] - Transgenic research Jun 2000 - 205-13 p. digital

Publication Type: Journal Article

0962-8819

10.1023/a:1008928713058 doi


Alanine Transaminase--blood
Animals
Antigens, CD--biosynthesis
Aspartate Aminotransferases--blood
CD55 Antigens--biosynthesis
Complement C3c--metabolism
Complement Inactivator Proteins--genetics
DNA Primers--chemistry
Fluorescent Antibody Technique, Indirect
Gene Expression
Graft Rejection--metabolism
Graft Survival
Humans
Interleukins--metabolism
Liver--metabolism
Membrane Cofactor Protein
Membrane Glycoproteins--biosynthesis
Mice
Mice, Transgenic
Models, Animal
P-Selectin--metabolism
RNA, Messenger--analysis
Reverse Transcriptase Polymerase Chain Reaction